Capricor Therap Cmn (CAPR) 3.66 $CAPR Capricor

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Capricor Therap Cmn (CAPR) 3.66 $CAPR

Capricor Therapeutics Reports Second Quarter 2016 Financial Results and Provides Clinical Update
PR Newswire - Mon Aug 15, 3:05PM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today provided an update on its clinical development programs directed toward the treatment of heart disease, including that associated with Duchenne Muscular Dystrophy (DMD), as well as defined the initial development path for its proprietary exosomes technology. Capricor also announced financial results for the quarter ended June 30, 2016.
CAPR: 3.66 (+0.06)

Investor Calendar Invites You to the Capricor Therapeutics Second Quarter 2016 Earnings Conference Call and Webcast Live on Monday, August 15, 2016
ACCESSWIRE - Mon Aug 15, 8:02AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 15, 2016 / Capricor Therapeutics, Inc. (NASDAQ: CAPR) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held August 15, 2016 at 4:30 PM Eastern Time.
CAPR: 3.66 (+0.06)

Capricor Therapeutics to Hold Second Quarter 2016 Business Update and Financial Results Conference Call and Webcast on Monday, August 15 at 4:30 p.m. ET
PR Newswire - Fri Aug 12, 8:00AM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today announced that company management will hold a conference call to discuss second quarter 2016 financial results and recent business highlights at 4:30 p.m. ET on Monday, August 15, 2016.
CAPR: 3.66 (+0.06)

Capricor Therapeutics to Present at JMP Life Sciences Conference
PR Newswire - Wed Jun 22, 5:00AM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today announced that Linda Marbán, Ph.D., its president and chief executive officer, is scheduled to present at the 2016 JMP Life Sciences Conference on June 22, 2016 at 9:00 am EDT in New York City.
CAPR: 3.66 (+0.06)

Capricor Therapeutics to Present at 2016 BIO International Convention
PR Newswire - Tue May 31, 6:00AM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today announced that Linda Marbán, Ph.D., its president and chief executive officer, is scheduled to present at the 2016 BIO International Convention on June 6, 2016 at 4:00 p.m. PDT in San Francisco.
CAPR: 3.66 (+0.06)

Capricor reports 1Q loss
Automated Insights - Thu May 12, 3:50PM CDT
BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $4.3 million in its first quarter.
CAPR: 3.66 (+0.06)

Capricor Therapeutics Provides Corporate Update and Reports First Quarter 2016 Financial Results
PR Newswire - Thu May 12, 3:05PM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today provided financial results for the first quarter ended March 31, 2016 as well as a business update.
CAPR: 3.66 (+0.06)

Investor Calendar Invites You to the Capricor Therapeutics First Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, May 12, 2016
ACCESSWIRE - Wed May 11, 3:11PM CDT
LOS ANGELES, CA / ACCESSWIRE / May 11, 2016 / Capricor Therapeutics, Inc. (NASDAQ: CAPR) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Thursday, May 12, 2016 at 4:30 PM Eastern Time.
CAPR: 3.66 (+0.06)

Akers Biosciences (AKER) Q1 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:52AM CDT
Akers Biosciences Inc (AKER) is expected to report first-quarter 2016 results on May 12.
CAPR: 3.66 (+0.06), STAA: 8.78 (-0.16), AKER: 3.58 (-0.10), VBLT: 4.11 (+0.08)

Capricor Therapeutics to Hold First Quarter 2016 Business Update and Financial Results Conference Call on May 12, 2016 at 4:30 p.m. EDT
PR Newswire - Thu May 05, 3:05PM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today announced that company management will hold a conference call to discuss first quarter 2016 financial results and recent business highlights at 4:30 p.m. EDT, May 12, 2016.
CAPR: 3.66 (+0.06)

Cardiovascular (CSII) Narrows Loss in Q3, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:36AM CDT
Cardiovascular Systems Inc. (CSII) reported third-quarter fiscal 2016 adjusted net loss per share of 31 cents.
CAPR: 3.66 (+0.06), CSII: 24.47 (-0.10), BAX: 46.73 (-0.16), CRDC: 2.35 (-0.15)

Abaxis (ABAX) Q4 Earnings Beat Estimates; Dividend Raised
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 9:21AM CDT
Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2016 earnings per share (EPS) of 36 cents from continuing operations.
BSX: 23.82 (-0.39), CAPR: 3.66 (+0.06), CSII: 24.47 (-0.10), ABAX: 50.14 (-0.71)

Zimmer Biomet (ZBH) Beats on Q1 Earnings, Margins Drag
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:51AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) reported first-quarter 2016 adjusted earnings per share (EPS) of $2.00, up 29.9% year over year.
BSX: 23.82 (-0.39), CAPR: 3.66 (+0.06), ZBH: 129.61 (-0.26), BAX: 46.73 (-0.16)

Phibro: Animal Health Grows amid Competition from Generics
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 1:35PM CDT
On Apr 7, 2016, we issued an updated research report on New Jersey-based Phibro Animal Health (PAHC).
CAPR: 3.66 (+0.06), CSII: 24.47 (-0.10), PAHC: 24.27 (+0.38), BAX: 46.73 (-0.16)

Capricor Therapeutics Announces DSMB Recommends Continuation of HOPE-Duchenne Clinical Trial
PR Newswire - Mon Apr 04, 7:30AM CDT
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today announced that the independent Data Safety Monitoring Board (DSMB) of the Phase I/II HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) clinical trial has completed its pre-specified review of the first patient cohort. Based on the DSMB's recommendation, enrollment in the trial will continue as planned. The HOPE-Duchenne trial is evaluating CAP-1002, Capricor's lead product candidate, in boys with Duchenne muscular dystrophy (DMD)-associated cardiomyopathy.
CAPR: 3.66 (+0.06)

Capricor Therapeutics to Present at 18th Annual BIO CEO & Investor Conference
PR Newswire - Tue Feb 02, 6:00AM CST
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today announced that Linda Marban, Ph.D., Chief Executive Officer, is scheduled to present at the 18th Annual BIO CEO & Investor Conference on February 8, 2016 at 9:30 a.m. EST in New York City.
CAPR: 3.66 (+0.06)

Align Technology Tops Q4 Earnings, Revenues; Margins Drop
Zacks Equity Research - Zacks Investment Research - Fri Jan 29, 10:20AM CST
Align Technology (ALGN) ended 2015 on an impressive note, with its fourth quarter outcome squarely exceeding the Zacks Consensus Estimate
CAPR: 3.66 (+0.06), ALGN: 92.90 (-0.29), LMAT: 18.38 (-0.08), VASC: 48.17 (-0.33)

Thermo Fisher Tops Q4 Earnings, Affymetrix Buy in the Cards
Zacks Equity Research - Zacks Investment Research - Thu Jan 28, 12:15PM CST
Thermo Fisher (TMO) ended 2015 on a promising note, delivering a better-than-expected fourth-quarter 2015 outcome that squarely beat the Zacks Consensus Estimate
CAPR: 3.66 (+0.06), TMO: 152.19 (-0.97), LMAT: 18.38 (-0.08), VASC: 48.17 (-0.33)

Mead Johnson Q4 Earnings, Sales Top Estimates: Fall Y/Y
Zacks Equity Research - Zacks Investment Research - Thu Jan 28, 11:55AM CST
Mead Johnson (MJN) ended 2015 on a promising note, squarely beating the Zacks Consensus Estimate in the fourth quarter of 2015.
CAPR: 3.66 (+0.06), MJN: 85.07 (+1.32), LMAT: 18.38 (-0.08), VASC: 48.17 (-0.33)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 326

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 0

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 31

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 74

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 117

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 419

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 160

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading

Top 5 Most Recently Viewed Articles

Inventiva's Significant Capital Boost Through Public Offering

Updated Category News Views 276

Inventiva's Upsized Public Offering Explained Inventiva, a clinical-stage biopharmaceutical company known for its focus on developing oral therapies targeting metabolic disorders, has recently announced the pricing details of its public offering. This significant initiative is set to raise around $150 million by selling approximately 38.96 million American Depositary...

Continue Reading
The Future of AI: How Innovations Drive Market Growth

Updated Category News Views 264

AI Market Growth Overview The artificial intelligence (AI) market is set for substantial growth, projected to increase by USD 237.4 billion from 2024 to 2028. The forecast indicates a remarkable compound annual growth rate (CAGR) of 30.07% during this period. This growth can largely be attributed to the rising demand for effective solutions in fraud prevention and the...

Continue Reading
commercetools Compilations: Innovations Driving Digital Growth

Updated Category News Views 177

Exciting Launch of commercetools Compilations commercetools has unveiled Compilations, a semi-annual showcase that highlights more than 50 product enhancements, demonstrating the organization’s dedication to innovation and improved customer experiences for users of the commercetools Platform. With over 13,000 deployments and 200 releases, this initiative significantly...

Continue Reading
AKOOL's Agentic Canvas: AI Execution Revolution

Updated Category News Views 23

AKOOL Elevates AI from Chat to Execution Well, folks, it looks like AKOOL is shaking things up in the world of artificial intelligence. Forget about AI that's just about chatting away and searching for answers like a digital gopher. This time, AKOOL is bringing something new to the table with its Agentic Canvas, and it's a real game-changer for anyone still fooling around...

Continue Reading
Qudian Inc. Transitions to High Templar Tech Limited

Updated Category News Views 222

Qudian Inc. Transitions to High Templar Tech Limited Qudian Inc., a technology-driven consumer company in China, has officially announced its rebranding to High Templar Tech Limited along with a change in its stock ticker from "QD" to "HTT". This significant decision reflects the company's evolving strategy and commitment to enhancing consumer experiences through...

Continue Reading